WCMC logo
PMKB
  • Login
KMT2A

Interpretations

By Variant(s)

KMT2A copy number gain

KMT2A copy number loss

KMT2A any mutation

By Tumor

  • Acinar Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Acinic Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Acute Myeloid Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Adenocarcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Adenoid Cystic Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Adenosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Ameloblastic Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Anaplastic Large Cell Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Angioimmunoblastic T-Cell Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Angiomatoid Fibrous Histiocytoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Angiomatosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Angiomyolipoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Angiosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Astrocytoma, Anaplastic
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Atypical Chronic Myeloid Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • B Lymphoblastic Leukemia/Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Basal Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Burkitt Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Carcinoid Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Carcinosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Cholangiocarcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chondrosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chordoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Choriocarcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chromophobe Renal Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chronic Lymphocytic Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chronic Myeloid Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chronic Myelomonocytic Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Chronic Neutrophilic Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Classical Hodgkin Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Clear Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Clear Cell Renal Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Craniopharyngioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Dermatofibrosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Desmoplastic Small Round Cell Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Diffuse Large B Cell Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Ductal Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Ependymoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Essential Thrombocythemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Ewing Sarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Fibromatosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Follicular Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Follicular Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Gastrointestinal Stromal Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Germ Cell Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Giant Cell Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Glioblastoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Glomus Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Granular Cell Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Hairy Cell Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Hemangioendothelioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Hepatocellular Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Histiocytic and Dendritic Cell Neoplasms
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Invasive Ductal Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Kaposi Sarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Langerhans Cell Histiocytosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Leiomyoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Leiomyosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Lipoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Liposarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Lobular Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Lymphoplasmacytic Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Malignant Mullerian Mixed Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mantle Cell Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Marginal Zone B Cell Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mast Cell Neoplasm
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • MDS with Ring Sideroblasts
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Medullary Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Medulloblastoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Melanoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Meningioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Merkel Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mesothelioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mucinous Tumors of Appendix
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mucinous Tumors of Ovary
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mucoepidermoid Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Myelodysplastic Syndrome
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Myeloproliferative Neoplasm
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Myxofibrosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Nasopharyngeal Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Neuroblastoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Neuroendocrine Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Neuroendocrine Neoplasm
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • NK Cell Lymphoproliferative Disorder
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • NLPHL
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Non-Small Cell Lung Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Oligodendroglioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Osteosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Papillary Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Papillary Renal Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Peripheral T Cell Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Pheochromocytoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Plasma Cell Disorder
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Polycythemia Vera
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Post-Transplant Lymphoproliferative Disorder
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Primary Myelofibrosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Primitive Neuroectodermal Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Renal Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Reninoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Retinoblastoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Rhabdomyosarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Sarcoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Schwannoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Serous Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Sex Cord Stromal Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Small Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Solid Pseudopapillary Tumor of Pancreas
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Spindle Cell Neoplasm
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Squamous Cell Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • T Cell Lymphoproliferative Disorder
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • T Lymphoblastic Leukemia/Lymphoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • T-Cell LGL Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Thymic Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Thymoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Urothelial Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Tumors of Peripheral Nerves
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Unknown
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Wilms Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Ependymoma, Anaplastic
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Astrocytoma, Pilocytic
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Ganglioglioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Neuroepithelial Neoplasm, NOS
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Pleomorphic Carcinoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Solitary Fibrous Tumor
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Neuroepithelial neoplasm, high grade
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Leukocytosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Thrombocytosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Monocytosis
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Cytopenia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Other Acute Leukemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Astrocytoma, NOS
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Acute Leukemia of Unspecified Cell Type
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Anemia, Unspecified
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Astrocytoma, Diffusely Infiltrating
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Diffuse Midline Glioma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Infiltrating Glioma, NOS
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Intraductal Papillary Mucinous Neoplasm (IPMN)
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Leukopenia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Lymphadenopathy
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Lymphocytosis, Symptomatic
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Monoclonal Gammopathy
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mucinous or Serous Cystic Neoplasms of Pancreas
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Mycosis Fungoides, Unspecified Site
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Oligodendroglioma, Anaplastic
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Pleomorphic Xanthoastrocytoma
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Rash and Other Nonspecific Skin Eruption
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Thrombocytopenia, Unspecified
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Eosinophilia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Myelodysplastic/Myeloproliferative Neoplasm
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Myeloid Neoplasm
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Polycythemia
    • KMT2A copy number gain, KMT2A copy number loss
    • KMT2A any mutation
  • Information
  • View History
  • Suggested Revisions
Interpretation 1830
Variant(s)KMT2A any mutation
Tumor(s)Acinar Cell Carcinoma
Acinic Cell Carcinoma
Acute Myeloid Leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adenosarcoma
Ameloblastic Tumor
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-Cell Lymphoma
Angiomatoid Fibrous Histiocytoma
Angiomatosis
Angiomyolipoma
Angiosarcoma
Astrocytoma, Anaplastic
Atypical Chronic Myeloid Leukemia
B Lymphoblastic Leukemia/Lymphoma
Basal Cell Carcinoma
Burkitt Lymphoma
Carcinoid Tumor
Carcinoma
Carcinosarcoma
Cholangiocarcinoma
Chondrosarcoma
Chordoma
Choriocarcinoma
Chromophobe Renal Cell Carcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Chronic Neutrophilic Leukemia
Classical Hodgkin Lymphoma
Clear Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Craniopharyngioma
Dermatofibrosarcoma
Desmoplastic Small Round Cell Tumor
Diffuse Large B Cell Lymphoma
Ductal Carcinoma
Ependymoma
Essential Thrombocythemia
Ewing Sarcoma
Fibromatosis
Follicular Carcinoma
Follicular Lymphoma
Gastrointestinal Stromal Tumor
Germ Cell Tumor
Giant Cell Tumor
Glioblastoma
Glomus Tumor
Granular Cell Tumor
Hairy Cell Leukemia
Hemangioendothelioma
Hepatocellular Carcinoma
Histiocytic and Dendritic Cell Neoplasms
Invasive Ductal Carcinoma
Kaposi Sarcoma
Langerhans Cell Histiocytosis
Leiomyoma
Leiomyosarcoma
Lipoma
Liposarcoma
Lobular Carcinoma
Lymphoplasmacytic Lymphoma
Malignant Mullerian Mixed Tumor
Mantle Cell Lymphoma
Marginal Zone B Cell Lymphoma
Mast Cell Neoplasm
MDS with Ring Sideroblasts
Medullary Carcinoma
Medulloblastoma
Melanoma
Meningioma
Merkel Cell Carcinoma
Mesothelioma
Mucinous Tumors of Appendix
Mucinous Tumors of Ovary
Mucoepidermoid Carcinoma
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
Myxofibrosarcoma
Nasopharyngeal Carcinoma
Neuroblastoma
Neuroendocrine Carcinoma
Neuroendocrine Neoplasm
NK Cell Lymphoproliferative Disorder
NLPHL
Non-Small Cell Lung Carcinoma
Oligodendroglioma
Osteosarcoma
Papillary Carcinoma
Papillary Renal Cell Carcinoma
Peripheral T Cell Lymphoma
Pheochromocytoma
Plasma Cell Disorder
Polycythemia Vera
Post-Transplant Lymphoproliferative Disorder
Primary Myelofibrosis
Primitive Neuroectodermal Tumor
Renal Cell Carcinoma
Reninoma
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Schwannoma
Serous Carcinoma
Sex Cord Stromal Tumor
Small Cell Carcinoma
Solid Pseudopapillary Tumor of Pancreas
Spindle Cell Neoplasm
Squamous Cell Carcinoma
T Cell Lymphoproliferative Disorder
T Lymphoblastic Leukemia/Lymphoma
T-Cell LGL Leukemia
Thymic Carcinoma
Thymoma
Urothelial Carcinoma
Tumors of Peripheral Nerves
Unknown
Wilms Tumor
Ependymoma, Anaplastic
Astrocytoma, Pilocytic
Ganglioglioma
Neuroepithelial Neoplasm, NOS
Pleomorphic Carcinoma
Solitary Fibrous Tumor
Neuroepithelial neoplasm, high grade
Leukocytosis
Thrombocytosis
Monocytosis
Cytopenia
Other Acute Leukemia
Astrocytoma, NOS
Acute Leukemia of Unspecified Cell Type
Anemia, Unspecified
Astrocytoma, Diffusely Infiltrating
Diffuse Midline Glioma
Infiltrating Glioma, NOS
Intraductal Papillary Mucinous Neoplasm (IPMN)
Leukopenia
Lymphadenopathy
Lymphocytosis, Symptomatic
Monoclonal Gammopathy
Mucinous or Serous Cystic Neoplasms of Pancreas
Mycosis Fungoides, Unspecified Site
Oligodendroglioma, Anaplastic
Pleomorphic Xanthoastrocytoma
Rash and Other Nonspecific Skin Eruption
Thrombocytopenia, Unspecified
Eosinophilia
Myelodysplastic/Myeloproliferative Neoplasm
Myeloid Neoplasm
Polycythemia
Tissue(s)Adrenal Gland
Anus
Ampulla (Pancreaticobiliary Duct)
Appendix
Bladder
Blood
Bone
Bone Marrow
Brain
Breast
Spinal Cord
Cervix
Chest Wall
Colon
Endometrium
Esophagus
Eye
Fallopian Tube
Fibroadipose Tissue
Gall Bladder
Kidney
Larynx
Liver
Lung
Lymph Node
Nasal Cavity
Oral Cavity
Ovary
Pancreas
Parathyroid
Penis
Peripheral Nervous System
Peritoneum
Pharynx
Pituitary
Placenta
Pleura
Prostate
Retroperitoneum
Salivary Gland
Seminal Vesicle
Skeletal Muscle
Skin
Small Intestine
Soft Tissue
Spleen
Stomach
Testis
Thymus
Thyroid
Tonsil
Unknown
Ureter
Uterus
Vagina
Rectum
Cartilage
Blood Vessel
Buccal Swab
Heart
Trachea
Salivary Duct
Spermatic Cord
Vulva
Brain, Infratentorial
Brain, Supratentorial
Gastroesophageal Junction
Sellar
Suprasellar
Peritoneal fluid
Pleural Fluid
Tier2
Interpretation

This gene is a known cancer gene.

Citations

Forbes, Simon A., David Beare, Harry Boutselakis, Sally Bamford, Nidhi Bindal, John Tate, Charlotte G. Cole, et al. "COSMIC: Somatic Cancer Genetics at High-Resolution." Nucleic Acids Research 45, no. D1 (January 4, 2017): D777--83. doi:10.1093/nar/gkw1121.

Disclaimer: You assume full responsibility for all risks associated with using this PMKB website. The IPM makes no guarantee of the comprehensiveness, reliability or accuracy of the information on this website and the IPM assumes no responsibility for errors in the information associated with this web site. Healthcare providers and patients must integrate all clinical and laboratory findings as well as information from a variety of sources before deciding on appropriate clinical care options.

  • Home
  • Browse
  • GGenes
  • VVariants
  • IInterpretations
  • TTumor Types
  • STissues
  • Activity
  • Contact
  • External Links
    • COSMIC
    • My Cancer Genome
    • TumorPortal
    • cBioPortal
    • cBioPortal for IPM
    • UniProt
    • Ensembl
    • PubMed
    • Clinical Trials
    • FDA Pharmacogenetics
    • Exome Variant Server
    • Google

Copyright IPM 2015-2018 - Build v.1.0.05